Menu
GeneBe

chr1-173870419-A-G

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001122770.3(ZBTB37):​c.194A>G​(p.Glu65Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)

Consequence

ZBTB37
NM_001122770.3 missense

Scores

2
7
9

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 8.95
Variant links:
Genes affected
ZBTB37 (HGNC:28365): (zinc finger and BTB domain containing 37) Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be part of chromatin. Predicted to be active in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.1993751).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ZBTB37NM_001122770.3 linkuse as main transcriptc.194A>G p.Glu65Gly missense_variant 3/5 ENST00000367701.10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ZBTB37ENST00000367701.10 linkuse as main transcriptc.194A>G p.Glu65Gly missense_variant 3/51 NM_001122770.3 P1Q5TC79-1
ZBTB37ENST00000695459.1 linkuse as main transcriptc.194A>G p.Glu65Gly missense_variant 3/5 P1Q5TC79-1
ZBTB37ENST00000367702.1 linkuse as main transcriptc.194A>G p.Glu65Gly missense_variant 3/45 Q5TC79-2
ZBTB37ENST00000367704.5 linkuse as main transcriptc.194A>G p.Glu65Gly missense_variant 3/42 Q5TC79-3

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsFeb 22, 2023The c.194A>G (p.E65G) alteration is located in exon 3 (coding exon 1) of the ZBTB37 gene. This alteration results from a A to G substitution at nucleotide position 194, causing the glutamic acid (E) at amino acid position 65 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.64
BayesDel_addAF
Uncertain
0.073
D
BayesDel_noAF
Benign
-0.13
CADD
Pathogenic
29
DANN
Uncertain
1.0
Eigen
Uncertain
0.38
Eigen_PC
Uncertain
0.50
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Uncertain
0.91
D;D;D;.
M_CAP
Benign
0.016
T
MetaRNN
Benign
0.20
T;T;T;T
MetaSVM
Benign
-0.72
T
MutationAssessor
Benign
-0.055
N;N;N;N
MutationTaster
Benign
1.0
D;D;D;D;D
PrimateAI
Uncertain
0.71
T
PROVEAN
Benign
-0.090
N;N;N;N
REVEL
Uncertain
0.32
Sift
Benign
0.22
T;T;T;T
Sift4G
Benign
0.21
T;T;T;T
Polyphen
0.99, 0.97
.;D;D;D
Vest4
0.30
MutPred
0.46
Gain of catalytic residue at M61 (P = 0.0349);Gain of catalytic residue at M61 (P = 0.0349);Gain of catalytic residue at M61 (P = 0.0349);Gain of catalytic residue at M61 (P = 0.0349);
MVP
0.25
MPC
0.44
ClinPred
0.96
D
GERP RS
5.6
Varity_R
0.23
gMVP
0.68

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr1-173839557; API